Citius Oncology
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $1,667 | $3,944 | $0 | $0 |
Gross Profit | 1,338 | 3,154 | ||
EBITDA | -26,807 | -4,650 | -4,675 | -4,944 |
EBIT | -5,223 | -4,944 | ||
Net Income | -26,609 | -5,534 | -4,996 | -5,369 |
Net Change In Cash | 1,667 | 3,944 | 0 | 0 |
Free Cash Flow | -3,967 | -7,354 | -5,534 | 0 |
Cash | 2,632 | 7,295 | 3,924 | |
Basic Shares | 100,027 | 87,462 | 80,944 | 71,552 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -23,486 | -20,572 | -12,121 | -4,856 |
EBIT | -20,572 | -12,121 | -4,856 | |
Net Income | -24,761 | -21,148 | -12,697 | -10,865 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,492 | 126 | -601 | -47 |
Cash | 3,924 | 26 | 289 | |
Basic Shares | 73,267 | 71,552 | 89,479 | 90,160 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.27 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.06 |
2025-06-30 | -$0.08 |